Lilly Endowment Inc - Feb 24, 2025 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
10%+ Owner
Signature
/s/ Diane M. Stenson, Vice President & Treasurer, on behalf of Lilly Endowment Inc.
Stock symbol
LLY
Transactions as of
Feb 24, 2025
Transactions value $
-$1,648,756,040
Form type
4
Date filed
2/25/2025, 04:00 PM
Previous filing
Feb 24, 2025
Next filing
Feb 26, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Sale -$5.65M -6.44K -0.01% $877.31 96.5M Feb 24, 2025 Direct F1
transaction LLY Common Stock Sale -$1.6B -1.82K 0% $878,401.00* 96.5M Feb 24, 2025 Direct F2
transaction LLY Common Stock Sale -$1.43M -1.63K 0% $879.47 96.5M Feb 24, 2025 Direct F3
transaction LLY Common Stock Sale -$1.17M -1.33K 0% $880.60 96.5M Feb 24, 2025 Direct F4
transaction LLY Common Stock Sale -$12.9M -14.6K -0.02% $881.52 96.5M Feb 24, 2025 Direct F5
transaction LLY Common Stock Sale -$5.61M -6.36K -0.01% $882.59 96.5M Feb 24, 2025 Direct F6
transaction LLY Common Stock Sale -$1.58M -1.79K 0% $883.78 96.5M Feb 24, 2025 Direct F7
transaction LLY Common Stock Sale -$1.5M -1.7K 0% $884.64 96.5M Feb 24, 2025 Direct F8
transaction LLY Common Stock Sale -$2.33M -2.63K 0% $885.95 96.5M Feb 24, 2025 Direct F9
transaction LLY Common Stock Sale -$5.1M -5.75K -0.01% $886.86 96.5M Feb 24, 2025 Direct F10
transaction LLY Common Stock Sale -$4.59M -5.17K -0.01% $887.87 96.5M Feb 24, 2025 Direct F11
transaction LLY Common Stock Sale -$3.76M -4.23K 0% $888.98 96.5M Feb 24, 2025 Direct F12
transaction LLY Common Stock Sale -$3.41M -3.84K 0% $890.00 96.5M Feb 24, 2025 Direct F13
transaction LLY Common Stock Sale -$2.29M -2.57K 0% $890.84 96.5M Feb 24, 2025 Direct F14
transaction LLY Common Stock Sale -$516K -578 0% $891.87 96.5M Feb 24, 2025 Direct F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $877.00 to $877.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), and (15) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $878.00 to $878.95, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $879.00 to $879.9383, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $880.0764 to $880.975, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $881.22 to $882.2105, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $882.22 to $883.215, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $883.285 to $884.27, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $884.33 to $885.3106, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $885.3767 to $886.36, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $886.3769 to $887.37, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $887.41 to $888.3896, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $888.48 to $889.4464, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $889.49 to $890.4754, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $890.553 to $891.532, inclusive.
F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $891.6064 to $892.23, inclusive.